Summary by Moomoo AI
Kosci Pharmaceutical - B (02171.HK) submitted a disclosure statement the next day on June 18, 2024, disclosing changes in the issuance of shares or treasury stock. The report shows that the total number of shares issued by the company remained unchanged at 575,653,415 shares between June 14, 2024 and June 18, 2024. However, the company conducted several share repurchases during this period, with a total of 1,939,000 shares repurchased, involving approximately HKD 12,000,000. All repurchased shares will be cancelled. According to the report, the stock repurchase transactions have been approved by the board of directors and comply with relevant listing rules and legal regulations. After the stock repurchase, the company will enter a month-long moratorium period until July 18, 2024, during which no new shares will be issued, and treasury shares will not be resold or transferred.